ArticleBMC complementary medicine and therapies2026
Dietary and non-dietary complementary and alternative medicine use in Saudi Arabia: the differential role of associated factors.
Article in BMC complementary medicine and therapies, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionComplementary and alternative medicine (CAM) is widely used among cancer patients in Saudi Arabia. However, there is currently a lack of analysis of disaggregated data on CAM use. This study predicts the likelihood of CAM use, particularly dietary or non-dietary supplements, based on patients’ socioeconomic characteristics, clinical conditions, and motivations for use. A clearer understanding of these dynamics will enable healthcare providers to align evidence-based guidance with patients’ preferences and needs.
methodsThis cross-sectional study was conducted in oncology departments to investigate the use of CAM, both dietary and non-dietary supplements, among cancer patients. We utilized validated instruments to record specific therapies and non-mainstream practices that patients used. Descriptive statistics were applied to summarize the variables of interest, while we categorized CAM usage into dietary and non-dietary supplements. Multivariate logistic regression was performed to explore the association between CAM use, demographic, socioeconomic factors, clinical profiles, and motivations or reasons for use, while examining whether educational attainment moderates the influence of social beliefs and gender on CAM use.
resultsMore than three-quarters (79%) of patients reported CAM use; 69% used dietary supplements, 71% used non-dietary supplements, and 62.5% used both. Patients with intermediate or secondary education were about twice as likely to use dietary and non-dietary supplements concurrently as those without formal education (OR = 2.15, 95% CI, 1.04-4.46, p = 0.04). By contrast, monthly income > $1,600 (vs. < $800) and having a hematologic malignancy were associated with lower odds of concurrently using dietary and non-dietary supplement use (OR = 0.58, 95% CI, 0.35-0.98, p = 0.04 & OR = 0.58, 95% CI, 0.35-0.98, p = 0.03). Women were twice as likely as men to use dietary supplements (OR = 2.17, 95% CI, 1.16-4.08, p = 0.02). Mood improvement was a strong motivator, where patients reporting this reason were more likely to use dietary supplements (OR = 2.67, 95% CI 1.26-5.66, p = 0.01) or non-dietary supplements (OR = 2.40, 95% CI 1.04-5.53, p = 0.04). Patients aged >50 years were less likely to use non-dietary supplements than younger patients (OR = 0.39, 95% CI, 0.17-0.90, p = 0.03). Educational attainment did not moderate the influence of social beliefs and gender on CAM use.
conclusionCAM use was highly prevalent and significantly predicted by socioeconomic factors, clinical profiles, and mood improvement as a motivation for use. There is a need for integrating proactive CAM use screening that addresses gender , age , and diagnosis specific patterns of CAM use and risks. Future studies that investigate patients’ decision-making and evaluate the safety and efficacy of commonly and locally used CAM supplements.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.